Olanzapine Impurity 13 is a synthetic byproduct formed during the coupling reaction in olanzapine manufacturing, featuring a benzothiazole-piperazine hybrid structure with a thiophene-bridged dibenzazepine core. Its scaffold incorporates a 10-methylthio substitution and a 3-chloro-2-methylphenyl group, diverging from the parent drug by an additional sulfur-containing heterocycle. This impurity arises from side-chain oxidation under reductive amination conditions. It functions as an HPLC reference standard for quantifying process-related impurities in olanzapine bulk drug substance.
On RequestCC1=CC2=C(NC3=C(N=C2N2CCN(CC2)C=2C4=C(NC5=C(N2)C=CC=C5)SC(=C4)C)C=CC=C3)S1
InChI=1S/C28H26N6S2/c1-17-15-19-25(29-21-7-3-5-9-23(21)31-27(19)35-17)33-11-13-34(14-12-33)26-20-16-18(2)36-28(20)32-24-10-6-4-8-22(24)30-26/h3-10,15-16,31-32H,11-14H2,1-2H3
MLQMWTKHBAHDAN-UHFFFAOYSA-N